These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26916005)

  • 21. Investigation of the site 2 pocket of Grp94 with KUNG65 benzamide derivatives.
    Pugh K; Xu H; Blagg BSJ
    Bioorg Med Chem Lett; 2024 Oct; 111():129893. PubMed ID: 39043265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endoplasmic Reticulum Chaperones at the Tumor Cell Surface and in the Extracellular Space].
    Brychtová V; Vojtěšek B
    Klin Onkol; 2016; 29 Suppl 4(Suppl 4):25-30. PubMed ID: 27846717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoplasmic Reticulum-resident Heat Shock Protein 90 (HSP90) Isoform Glucose-regulated Protein 94 (GRP94) Regulates Cell Polarity and Cancer Cell Migration by Affecting Intracellular Transport.
    Ghosh S; Shinogle HE; Galeva NA; Dobrowsky RT; Blagg BS
    J Biol Chem; 2016 Apr; 291(16):8309-23. PubMed ID: 26872972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90.
    Huck JD; Que NLS; Immormino RM; Shrestha L; Taldone T; Chiosis G; Gewirth DT
    J Biol Chem; 2019 Nov; 294(44):16010-16019. PubMed ID: 31501246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chaperone gp96-independent inhibition of endotoxin response by chaperone-based peptide inhibitors.
    Wu S; Dole K; Hong F; Noman AS; Issacs J; Liu B; Li Z
    J Biol Chem; 2012 Jun; 287(24):19896-903. PubMed ID: 22532561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural transitions modulate the chaperone activities of Grp94.
    Mirikar D; Bushman Y; Truman AW
    Trends Biochem Sci; 2024 Sep; 49(9):752-753. PubMed ID: 38906726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRAP1: a viable therapeutic target for future cancer treatments?
    Lettini G; Maddalena F; Sisinni L; Condelli V; Matassa DS; Costi MP; Simoni D; Esposito F; Landriscina M
    Expert Opin Ther Targets; 2017 Aug; 21(8):805-815. PubMed ID: 28664757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. gp96 leads the way for toll-like receptors.
    Harding CV
    Immunity; 2007 Feb; 26(2):141-3. PubMed ID: 17307701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum.
    Marzec M; Eletto D; Argon Y
    Biochim Biophys Acta; 2012 Mar; 1823(3):774-87. PubMed ID: 22079671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GP96 is a GARP chaperone and controls regulatory T cell functions.
    Zhang Y; Wu BX; Metelli A; Thaxton JE; Hong F; Rachidi S; Ansa-Addo E; Sun S; Vasu C; Yang Y; Liu B; Li Z
    J Clin Invest; 2015 Feb; 125(2):859-69. PubMed ID: 25607841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone.
    Liu B; Yang Y; Qiu Z; Staron M; Hong F; Li Y; Wu S; Li Y; Hao B; Bona R; Han D; Li Z
    Nat Commun; 2010 Sep; 1(6):79. PubMed ID: 20865800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel quaternary domain interactions in the Hsp90 chaperone, GRP94.
    Chu F; Maynard JC; Chiosis G; Nicchitta CV; Burlingame AL
    Protein Sci; 2006 Jun; 15(6):1260-9. PubMed ID: 16731965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic tumor-cell-based vaccines secreting endoplasmic reticulum chaperone gp96.
    Podack ER; Raez LE
    Expert Opin Biol Ther; 2007 Nov; 7(11):1679-88. PubMed ID: 17961091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages.
    Yang Y; Liu B; Dai J; Srivastava PK; Zammit DJ; Lefrançois L; Li Z
    Immunity; 2007 Feb; 26(2):215-26. PubMed ID: 17275357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer.
    Crowley VM; Huard DJE; Lieberman RL; Blagg BSJ
    Chemistry; 2017 Nov; 23(62):15775-15782. PubMed ID: 28857290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose-regulated protein 94/glycoprotein 96 elicits bystander activation of CD4+ T cell Th1 cytokine production in vivo.
    Baker-LePain JC; Sarzotti M; Nicchitta CV
    J Immunol; 2004 Apr; 172(7):4195-203. PubMed ID: 15034032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The endoplasmic reticulum chaperone BiP is a closure-accelerating cochaperone of Grp94.
    Huang B; Sun M; Hoxie R; Kotler JLM; Friedman LJ; Gelles J; Street TO
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35078937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and Functional Analysis of GRP94 in the Closed State Reveals an Essential Role for the Pre-N Domain and a Potential Client-Binding Site.
    Huck JD; Que NL; Hong F; Li Z; Gewirth DT
    Cell Rep; 2017 Sep; 20(12):2800-2809. PubMed ID: 28930677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HSP90 and Immune Modulation in Cancer.
    Graner MW
    Adv Cancer Res; 2016; 129():191-224. PubMed ID: 26916006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Old and New Approaches to Target the Hsp90 Chaperone.
    Sanchez J; Carter TR; Cohen MS; Blagg BSJ
    Curr Cancer Drug Targets; 2020; 20(4):253-270. PubMed ID: 31793427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.